Yin, Kai <br/><br/>
Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(-/-) mice possibly via activated STAT3-mediated upregulation of tristetraprolin.  [electronic resource] 

 -  Acta pharmacologica Sinica  Jun 2013 
 - 837-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1745-7254 
<br/><br/><label>Standard No.: </label>10.1038/aps.2013.10  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apolipoprotein A-I--administration & dosage<br/>Apolipoproteins E--genetics<br/>Atherosclerosis--pathology<br/>Cytokines--metabolism<br/>Humans<br/>Inflammation--pathology<br/>Inflammation Mediators--metabolism<br/>Lipopolysaccharides--toxicity<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>STAT3 Transcription Factor--metabolism<br/>Tristetraprolin--genetics<br/>Up-Regulation